Original Article

Contraceptive Practices, Preferences, and Barriers Among Abortion Clients in North Carolina

Authors: Amy G. Bryant, MD, MSCR, Ilene S. Speizer, PhD, Jennifer C. Hodgkinson, MA, Alison Swiatlo, MPH, Siân L. Curtis, PhD, Krista Perreira, PhD

Abstract

Objectives: Abortion clinics provide an ideal setting for women to receive contraceptive care because the women served may not have other contacts with the health system and are at risk for unintended pregnancies. The objective of this study was to understand practices, preferences, and barriers to use of contraception for women obtaining abortions at clinics in North Carolina.

Methods: We conducted a cross-sectional survey of abortion clients and facilities at 10 abortion clinics in North Carolina. We collected data on contraceptive availability at each clinic. We collected individual responses on women’s experiences obtaining contraception before the current pregnancy and their intentions for future use of contraception.

Results: From October 2015 to February 2016, 376 client surveys were completed at 9 clinics, and 10 clinic surveys were completed. Almost one-third of women (29%) reported that they had wanted to use contraception in the last year but were unable. Approximately three-fourths of respondents (76%) stated that they intend to use contraception after this pregnancy. Approximately one-fifth of women stated that would like to use long-acting reversible contraception (LARC) after this abortion. Only the clinics that accepted insurance for abortion and other services provided LARC at the time of the abortion (40%).

Conclusions: This study provides a unique, statewide view into the contraceptive barriers for women seeking abortion in North Carolina. Addressing the relatively high demand for LARC after abortion could help significantly reduce unintended pregnancy and recourse to abortion in North Carolina.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Aztlan-James EA, McLemore M, Taylor D. Multiple unintended pregnancies in U.S. women: a systematic review. Womens Health Issues 2017;27:407-413.
 
2. Madden T, Westhoff C. Rates of follow-up and repeat pregnancy in the 12 months after first-trimester induced abortion. Obstet Gynecol 2009;113:663-668.
 
3. Prager SW, Steinauer JE, Foster DG, et al. Risk factors for repeat elective abortion. Am J Obstet Gynecol 2007;197:575.e1-6.
 
4. Marrs RP, Kletzky OA, Howard WF, et al. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol 1979;135:731-736.
 
5. Schreiber CA, Sober S, Ratcliffe S, et al. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception 2011;84:230-233.
 
6. Langston AM, Joslin-Roher SL, Westhoff CL. Immediate postabortion access to IUDs, implants and DMPA reduces repeat pregnancy within 1 year in a New York City practice. Contraception 2014;89:103-108.
 
7. Birgisson NE, Zhao Q, Secura GM, et al. Preventing unintended pregnancy: the Contraceptive CHOICE Project in review. J Womens Health (Larchmt) 2015;24:349-353.
 
8. Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med 2012;366:1998-2007.
 
9. Roberts H, Silva M, Xu S. Post abortion contraception and its effect on repeat abortions in Auckland, New Zealand. Contraception 2010;82:260-265.
 
10. Rose SB, Lawton BA, Brown SA. Uptake and adherence to long-acting reversible contraception post-abortion. Contraception 2010;82:345-353.
 
11. Cremer M, Bullard KA, Mosley RM, et al. Immediate vs. delayed post-abortal copper T 380A IUD insertion in cases over 12 weeks of gestation. Contraception 2011;83:522-527.
 
12. Kavanaugh ML, Carlin EE, Jones RK. Patients' attitudes and experiences related to receiving contraception during abortion care. Contraception 2011;84:585-593.
 
13. Matulich M, Cansino C, Culwell KR, et al. Understanding women' desires for contraceptive counseling at the time of first-trimester surgical abortion. Contraception 2014;89:36-41.
 
14. Stacey RE, Dempsey A. The influence of trust in health care systems on postabortion contraceptive choice. Contraception 2015;92:458-462.
 
15. Jerman J, Jones RK, Onda T. Characteristics of U.S. abortion patients in 2014 and changes since 2008. https://www.guttmacher.org/report/characteristics-us-abortion-patients-2014. Published 2016. Accessed March 29, 2018.
 
16. Jones RK, Jerman J. Abortion incidence and service availability In the United States, 2014. Perspect Sex Reprod Health 2017;49:17-27.
 
17. Dehlendorf C, Bellanca H, Policar M. Performance measures for contraceptive care: what are we actually trying to measure? Contraception 2015;91:433-437.
 
18. Goyal V, Canfield C, Aiken AR, et al. Postabortion contraceptive use and continuation when long-acting reversible contraception is free. Obstet Gynecol 2017;129:655-662.
 
19. Kavanaugh ML, Jones RK, Finer LB. How commonly do US abortion clinics offer contraceptive services? Contraception 2010;82:331-336.
 
20. Rocca CH, Thompson KM, Goodman S, et al. Funding policies and postabortion long-acting reversible contraception: results from a cluster randomized trial. Am J Obstet Gynecol 2016;214:716. e1-8.
 
21. Krashin JW, Stuart GS, Garrett J, et al. Contraception insurance coverage and receipt of long-acting reversible contraception or depot medroxyprogesterone acetate on the day of abortion. Obstet Gynecol 2017;130:109-117.
 
22. Harris LH, Martin L, Debbink M, et al. Physicians, abortion provision and the legitimacy paradox. Contraception 2013;87:11-16.
 
23. Moslin TA, Rochat RW. Contraceptive use among clients of the Atlanta Feminist Women' Health Center at three to five weeks post-abortion. Matern Child Health J 2011;15:759-764.
 
24. Madden T, Secura GM, Allsworth JE, Peipert JF. Comparison of contraceptive method chosen by women with and without a recent history of induced abortion. Contraception 2011;84:571-577.
 
25. Frost JJ, Darroch JE. Factors associated with contraceptive choice and inconsistent method use, United States, 2004. Perspect Sex Reprod Health 2008;40:94-104.
 
26. Marshall C, Guendelman S, Mauldon J, et al. Young women' contraceptive decision making: do preferences for contraceptive attributes align with method choice? Perspect Sex Reprod Health 2016;48:119-127.
 
27. Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol 2014;57:659-673.